Fund vehicle
Global Health Investment Fund I
The Global Health Investment Fund I (GHIF) is a pioneering $108 million social impact investment fund launched in 2013. Designed as a public-private partnership, the fund provides financing to advance the late-stage development of drugs, vaccines, diagnostics, and other interventions for diseases that disproportionately burden low- and middle-income countries (LMICs). The fund targets high-potential medical R&D opportunities addressing infectious diseases (e.g., malaria, TB, HIV, cholera) and maternal/infant health issues. To attract private capital, the fund utilised an innovative "double bottom line" structure, in which the Bill & Melinda Gates Foundation and the Swedish International Development Cooperation Agency (Sida) provided partial downside protection to investors.
- Manager
- Global Health Investments Corporation (GHIC)
- Vintage
- 2012
- Strategy
- Venture Capital
- Target size
- $100m
- Size
- $108m
- Status
- Fully Invested
Disclosed limited partners
- Children's Investment Fund Foundation (CIFF)
- Gates Foundation (Bill & Melinda Gates Foundation)
- GlaxoSmithKline (GSK)
- Global Health Investments Corporation (GHIC)
- Grand Challenges Canada
- Impact Assets
- International Finance Corporation (IFC)
- JPMorgan Chase
- KfW Development Bank
- Lampert Byrd Foundation
- Merck & Co., Inc.
- Storebrand
- Swedish International Development Cooperation Agency (SIDA)
- The Pfizer Foundation
Sources
- Partner Researchers, accessed 14 November 2026